Medix Biochemica is following the worldwide COVID-19 situation constantly and we are making every effort to minimize the impact of this situation to our customers.
We do not estimate any significant disruptions in the manufacturing of our products at our sites in Espoo, Finland or in St. Louis, Missouri, USA, and we do not foresee any shortages in the supply of our products. However, we encourage our customers to make any needed updates to their orders quickly so we can plan our manufacturing accordingly. We are also taking precautions at our manufacturing sites to make sure that our employees stay healthy.
In addition, our logistic teams are intensely focusing on ensuring that the product deliveries will take place without interruptions. In case any changes in planned deliveries are foreseeable, we will be in direct contact with you.
Our teams are prepared to support our customers the best possible way. We are making every effort to minimize the impact of this situation to our customers and we want ensure the timeliness and quality of the work we do.
Should you have any specific questions, please do not hesitate to get in touch with your local business contact or via email: